In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 120 for your search:
Cancer Type/Condition:  Prostate cancer
Trial Status:  Active
Sponsor of Trial:  NCI
Start Over
        Show
1.

Phase: Phase IV
Type: Prevention
Status: Active
Age: 55 and over
Sponsor: NCI, Other
Protocol IDs: ROI10-352, R01CA138627, NCT01296672

2.

Phase: Phase III
Type: Treatment
Status: Active
Age: Adult
Sponsor: NCI, Other
Protocol IDs: CDR0000064184, SWOG-9346, CAN-NCIC-PR8, CALGB-9594, ECOG-S9346, EORTC-30985, CAN-NCIC-JPR8, INT-0162, PR8, NCT00002651

3.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000462099, ECOG-E3805, E3805, NCT00309985

4.

Phase: Phase III
Type: Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: N0574, NCCTG-N0574, ACOSOG-N0574, CDR0000499633, NCI-2009-00653, NCT00377156

5.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000526353, CALGB-90203, NCT00430183

6.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: RTOG 0534, CDR0000577574, NCI-2009-00733, NCT00567580

7.

Phase: Phase III
Type: Natural history/Epidemiology
Status: Active
Age: 55 and over (50 and over for African Americans)
Sponsor: NCI, Other
Protocol IDs: CDR0000617778, S0000B, U10CA037429, R01EY014418, SWOG-S0000B, NCT00784225

8.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: I 128308, NCI-2009-01530, P30CA016056, RPCI-I-128308, NCT00887432

9.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: RTOG 0815, CDR0000648194, NCI-2011-01948, NCT00936390

10.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2011-01952, CDR0000649174, CALGB 90601, P30CA014236, U10CA031946, NCT00942331

11.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: RTOG-0924, CDR0000701128, NCI-2011-02674, NCT01368588

12.

Phase: Phase III
Type: Health services research, Supportive care
Status: Active
Age: 21 and over
Sponsor: NCI, Other
Protocol IDs: 1R01CA127493-01A2, NCT01365182

13.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: RTOG 1115, CDR0000727326, NCI-2012-00700, NCT01546987

14.

Phase: Phase III
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 11113, NCI-2012-00558, NCT01613651

15.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 11-497, NCT01617161

16.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: S1216, SWOG-S1216, NCI-2012-02876, NCT01809691

17.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: A031201, U10CA031946, NCI-2013-01737, NCT01949337

18.

Phase: Phase II, Phase I
Type: Diagnostic
Status: Active
Age: Over 18
Sponsor: NCI, Other
Protocol IDs: RA-2008-069, R21CA139687, NCT00928252

19.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 4P-09-9, NCI-2009-01418, NCT01240629

20.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 2011-031, NCI-2011-03216, NCT01468532

21.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: 140015, 14-C-0015, NCT01989546

22.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: IRB13-0979, NCI-2013-02151, CDMRP-PC121149, P30CA014599, NCT02012296

23.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000581020, UPCC-03806, SANOFI-AVENTIS-UPCC-03806, NCT00589420

24.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 85
Sponsor: NCI, Other
Protocol IDs: CDR0000595004, JHOC-J07122, JHOC-NA_00010227, J07122, NCT00670046

25.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: IRB00005688, NCI-2010-02037, SOL-09105-LM, OHSU-5688, P30CA069533, NCT01253642
1     
New Search